Villalba brings more than 30 years of industry experience in developing and commercialising innovative products and therapies
The patent encompasses a system that measures follicle-stimulating hormones, oestrogen, LH, and progesterone markers
Stigma and misinformation are putting women off attending smear tests and essential checks, research reveals
The partnership aims to serve more than 100,000 women in the next five years
HBMAT's programmes aim to deliver precision therapies for endocrine disorders
The appointments "showcase the company's commitment to deploying the most rigorous privacy and security standards", says Flo
The survey is open to anyone involved in producing, manufacturing, marketing or distributing femtech products and services
The company will expand its range of services, including guided meditations, mindfulness exercises and mental health support
Despite promising signs of cancer screening being on the rise, gender inequalities remain
The study will evaluate an investigational digital therapeutic for the treatment of mild to moderate postpartum depression
